Report an error

Spotted something inaccurate in “Bispecific HIV Antibody 10E8.4/iMab Clears Phase 1 Safety Bar Across Dose Levels”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.